Changeflow GovPing Healthcare & Life Sciences ANSM Safety Alert for Soltive SuperPulsed Laser...
Priority review Notice Amended Final

ANSM Safety Alert for Soltive SuperPulsed Laser Systems

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Published
Detected
Email

Summary

The French ANSM has issued a safety alert (R2607992) regarding Soltive SuperPulsed laser systems, following a security action initiated by Olympus. Affected users have been notified directly by the manufacturer.

Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert (R2607992) concerning Soltive SuperPulsed laser systems. This alert is based on a security action implemented by the manufacturer, Olympus, and users have been directly informed via correspondence from the company. The alert is intended for pharmacies within healthcare facilities and distributors.

Healthcare providers and distributors using these laser systems should review the safety information provided by Olympus, which was attached to the ANSM notification. While this is a safety alert and not a regulatory mandate with explicit penalties, failure to address potential safety concerns could lead to patient harm and reputational damage. Compliance officers should ensure their facilities have received and acted upon the manufacturer's specific guidance.

What to do next

  1. Review safety alert R2607992 from ANSM
  2. Consult the security action letter from Olympus dated 2026-03-18
  3. Ensure all relevant personnel are aware of and adhering to manufacturer safety guidelines for Soltive SuperPulsed laser systems

Archived snapshot

Mar 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

A+ A-

Information n° R2607992 destinée aux pharmacies d'usage intérieur des établissements de santé et aux distributeurs L'ANSM a été informée de la mise en œuvre d’une information de sécurité par la société Olympus. Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2607992.

Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité Téléchargez le courrier de la société Olympus (18/03/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers
Geographic scope
National (France) National (France)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Medical Devices Product Safety

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!